BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36219392)

  • 41. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.
    Cheng D; Zhao S; Tang H; Zhang D; Sun H; Yu F; Jiang W; Yue B; Wang J; Zhang M; Yu Y; Liu X; Sun X; Zhou Z; Qin X; Zhang X; Yan D; Wen Y; Peng Z
    Oncotarget; 2016 Jul; 7(29):45199-45213. PubMed ID: 27286257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PDGFA-associated protein 1 is a novel target of c-Myc and contributes to colorectal cancer initiation and progression.
    Cui HY; Wei W; Qian MR; Tian RF; Fu X; Li HW; Nan G; Yang T; Lin P; Chen X; Zhu YM; Wang B; Sun XX; Dou JH; Jiang JL; Li L; Wang SJ; Chen ZN
    Cancer Commun (Lond); 2022 Aug; 42(8):750-767. PubMed ID: 35716012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis.
    Taha-Mehlitz S; Bianco G; Coto-Llerena M; Kancherla V; Bantug GR; Gallon J; Ercan C; Panebianco F; Eppenberger-Castori S; von Strauss M; Staubli S; Bolli M; Peterli R; Matter MS; Terracciano LM; von Flüe M; Ng CKY; Soysal SD; Kollmar O; Piscuoglio S
    Theranostics; 2021; 11(9):4011-4029. PubMed ID: 33754045
    [No Abstract]   [Full Text] [Related]  

  • 46. MYC-Activated LncRNA
    Wu QN; Luo XJ; Liu J; Lu YX; Wang Y; Qi J; Liu ZX; Huang QT; Liu ZK; Lu JB; Jin Y; Pu HY; Hu PS; Zheng JB; Zeng ZL; Ju HQ; Xie D; Zhao Q; Xu R
    Cancer Res; 2021 May; 81(10):2636-2650. PubMed ID: 33782099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
    Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
    Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
    Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
    Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation.
    Coni S; Serrao SM; Yurtsever ZN; Di Magno L; Bordone R; Bertani C; Licursi V; Ianniello Z; Infante P; Moretti M; Petroni M; Guerrieri F; Fatica A; Macone A; De Smaele E; Di Marcotullio L; Giannini G; Maroder M; Agostinelli E; Canettieri G
    Cell Death Dis; 2020 Dec; 11(12):1045. PubMed ID: 33303756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.
    Li Y; Bavarva JH; Wang Z; Guo J; Qian C; Thibodeau SN; Golemis EA; Liu W
    Oncogene; 2011 Jun; 30(23):2633-43. PubMed ID: 21317929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CAMSAP2 promotes colorectal cancer cell migration and invasion through activation of JNK/c-Jun/MMP-1 signaling pathway.
    Wang X; Liu Y; Ding Y; Feng G
    Sci Rep; 2022 Oct; 12(1):16899. PubMed ID: 36207462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells.
    Shiou SR; Singh AB; Moorthy K; Datta PK; Washington MK; Beauchamp RD; Dhawan P
    Cancer Res; 2007 Feb; 67(4):1571-9. PubMed ID: 17308096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
    Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
    Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Silence of circBANP increases radiosensitivity of colorectal cancer cells and inhibits growth of subcutaneous xenografts by up-regulating miR-338-3p expression].
    Xie Y; Liu JB; Li JM; Zhang C; Lu CX; Wen ZJ
    Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):533-540. PubMed ID: 34034472
    [No Abstract]   [Full Text] [Related]  

  • 56. Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice.
    Bi X; Pohl NM; Qian Z; Yang GR; Gou Y; Guzman G; Kajdacsy-Balla A; Iozzo RV; Yang W
    Carcinogenesis; 2012 Feb; 33(2):326-30. PubMed ID: 22159220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids.
    Cave DD; Hernando-Momblona X; Sevillano M; Minchiotti G; Lonardo E
    Theranostics; 2021; 11(12):5686-5699. PubMed ID: 33897875
    [No Abstract]   [Full Text] [Related]  

  • 58. Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling.
    Wang C; Yue Y; Shao B; Qiu Z; Mu J; Tang J; Han X; Xiang T; Ren G
    Cell Physiol Biochem; 2017; 41(5):1709-1724. PubMed ID: 28365691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.
    Ai X; Wu Y; Zhang W; Zhang Z; Jin G; Zhao J; Yu J; Lin Y; Zhang W; Liang H; Datta PK; Zhang M; Zhang B; Chen X
    Cancer Biol Ther; 2013 Nov; 14(11):1059-67. PubMed ID: 24025354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.